Skip to main content
SpringerLink
Log in

Locoregional Chemotherapy for Hepatic Metastasis of Colorectal Cancer

  • Chapter
  • First Online:
Liver Metastases

  • 908 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2007. CA Cancer J Clin. 2007; 57: 43–66.

    Article  PubMed  Google Scholar 

  2. Fong Y, Blumgart L. Hepatic colorectal metastases: current status of surgical therapy. Oncology 1998; 12: 1489–98.

    PubMed  CAS  Google Scholar 

  3. Fong Y, Cohen A, Fortner J, et al. Liver resection for colorectal metastases. J Clin Oncol. 1997; 15: 938–46.

    PubMed  CAS  Google Scholar 

  4. Fong Y, Salo J. Surgical therapy of hepatic colorectal metastases. Semin Oncol. 1999; 26: 514–23.

    PubMed  CAS  Google Scholar 

  5. Kemeny N, Fata F. Hepatic-arterial chemotherapy. Lancet. Oncol. 2001; 2: 418–28.

    Article  PubMed  CAS  Google Scholar 

  6. Bilchik AJ. Arterial chemotherapy as adjuvant and palliative treatment of hepatic colorectal metastases: an update. Surg Oncol Clin N Am. 2003; 12: 193–210.

    Article  PubMed  Google Scholar 

  7. Kemeny N, Gonen M, Sullivan D, et al. Phase I study of hepatic arterial infusion of floxuridine and dexamethasone with systemic irinotecan for unresectable hepatic metastases from colorectal cancer. J Clin Oncol. 2001; 19: 2687–95.

    PubMed  CAS  Google Scholar 

  8. Chang AE, Schneider PD, Sugarbaker PH, et al. A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases. Ann Surg. 1987; 206: 685–93.

    Article  PubMed  CAS  Google Scholar 

  9. Grosso M, Scarrone A, Pedrazzini F, et al. Intra-arterial hepatic chemotherapy: management of liver tumors by percutaneous port-a-cath positioning. J Exp Clin Cancer Res. 2003; 22: 171–5.

    PubMed  CAS  Google Scholar 

  10. Kemeny N, Daly J, Reichman B, et al. Intrahepatic or systemic infusion fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. A randomized trial. Ann Intern Med. 1987; 107: 459–65.

    CAS  Google Scholar 

  11. Kemeny N, Conti J, Cohen A, et al. Phase II study of hepatic fluorouridine, leucovorin and dexamethasone for unresectable liver metastases from colorectal carcinoma. J Clin Oncol. 1994; 12: 2288–95.

    PubMed  CAS  Google Scholar 

  12. Kemeny N, Huang Y, Cohen AM, et al. Hepatic arterial infusion of chemotherapy after resection of hepatic metastasis from colorectal cancer. N Engl J Med. 1999; 341: 2039–48.

    Article  PubMed  CAS  Google Scholar 

  13. Lorenz M, Muller HH, Schramm H, et al. Randomized trial of surgery versus surgery followed by adjuvant hepatic arterial infusion with 5-fluorouracil and folic acid for liver metastases of colorectal cancer. German Cooperative on Liver Metastases. Ann Surg. 1998; 228: 756–62.

    CAS  Google Scholar 

  14. Chung KY, Kemeny N. Regional and systemic chemotherapy for primary hepatobiliary cancer and for colorectal cancer metastatic to the liver. Semin Radiat Oncol. 2005; 15: 284–98.

    Article  PubMed  Google Scholar 

  15. Kemeny N, Jarnagin W, Paty P, et al. Phase I trial of systemic oxaliplatin combination chemotherapy with hepatic arterial infusion in patients with unresectable liver metastases from colorectal cancer. J Clin Oncol. 2005; 23: 4888–96.

    Article  PubMed  CAS  Google Scholar 

  16. Rougier P, Laplanche A, Huguier M, et al. Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: long term results of a prospective randomized trial. J Clin Oncol. 1992; 10: 1112–8.

    PubMed  CAS  Google Scholar 

  17. Kemeny N. Current approaches for liver-only metastases in colorectal cancer. Commun Oncol. 2006; 3: 26–35.

    Google Scholar 

  18. Franklin ME Jr, Gonzalez J Jr. Laparoscopic placement of hepatic artery catheter for regional chemotherapy infusion: technique, benefits, and complications. Surg Laparosc Endosc Percutan Tech. 2002; 12: 398–407.

    Article  PubMed  Google Scholar 

  19. Franklin M, Trevino J, Hernandez-Oaknin H, et al. Laparoscopic hepatic artery catheterization for regional chemotherapy: is this the best current option for liver metastatic disease? Surg Endosc. 2006; 20: 554–8.

    Article  PubMed  CAS  Google Scholar 

  20. Hohn DC, Stagg RJ, Friedman MA, et al. A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: the Northern California Oncology Group trial. J Clin Oncol. 1989; 7: 1646–54.

    PubMed  CAS  Google Scholar 

  21. Kemeny N, Seiter K, Niedzwiecki D, et al. A randomized trial of intrahepatic infusion of fluorodeoxyuridine with dexamethasone versus fluorodeoxyuridine alone in the treatment of metastatic colorectal cancer. Cancer. 1992; 69: 327–34.

    Article  PubMed  CAS  Google Scholar 

  22. Martin JK, O’Connell MJ, Wieand HS, et al. Intra-arterial floxuridine vs. systemic fluorouracil for hepatic metastases from colorectal cancer. Arch Surg. 1990; 125: 1022–27.

    Article  PubMed  Google Scholar 

  23. Allen-Mersh TG, Earlam S, Fordy C, et al. Quality of life and survival with continuous hepatic artery floxuridine infusion for colorectal liver metastases. Lancet. 1994; 344: 1255–60.

    Article  PubMed  CAS  Google Scholar 

  24. Lorenz M, Muller HH. Randomized, multi-center trial of fluorouracil plus leucovorin administered either via hepatic arterial or intravenous infusion versus fluorodeoxyuridine administered via hepatic arterial infusion in patients with nonresectable liver metastases from colorectal carcinoma. J Clin Oncol. 2000; 18: 243–54.

    PubMed  CAS  Google Scholar 

  25. Rothbarth J, Pijl ME, Vahrmeijer AL, et al. Isolated hepatic perfusion with high-dose melphalan for the treatment of colorectal metastasis confined to the liver. Br J Surg. 2003; 90: 1391–7.

    Article  PubMed  CAS  Google Scholar 

  26. Rougier P, Van Cutsem E, Bajetta E, et al. Randomized trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer. Lancet. 1998; 352: 1407–13.

    Article  PubMed  CAS  Google Scholar 

  27. Shimada Y, Yoshino M, Wakui A, et al. Phase II study of CPT-11, a new camptothecin derivative, in metastatic colorectal cancer. CPT-11 Gastrointestinal Cancer Study Group. J Clin Onocol. 1993; 11: 909–13.

    CAS  Google Scholar 

  28. Cunningham D, Pyrhonen S, James R, et al. Randomized trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure in patients with metastatic colorectal cancer. Lancet. 1998; 352: 1413–8.

    Article  PubMed  CAS  Google Scholar 

  29. Cunningham D, Humblet Y, Siena S, et al. Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer. N Engl J Med. 2004; 351: 337–45.

    Article  PubMed  CAS  Google Scholar 

  30. Giantonio BJ, Catalano PJ, Meropol NJ, et al. Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: results from the Eastern Cooperative Oncology Group Study E3200. J Clin Oncol. 2007; 25: 1539–44.

    Article  PubMed  CAS  Google Scholar 

  31. Kemeny MM, Adak S, Gray B, et al. Combined modality treatment for resectable metastatic colorectal carcinoma to the liver: surgical resection of hepatic metastases in combination with continuous infusion of chemotherapy—an intergroup study. J Clin Oncol. 2002; 20: 1499–1505.

    Article  PubMed  Google Scholar 

  32. Wagman LD, Kemeny MM, Leong L, et al. A prospective, randomized evaluation of the treatment of colorectal cancer metastatic to the liver. J Clin Oncol. 1990; 8: 1885–93.

    PubMed  CAS  Google Scholar 

  33. Kemeny N, Niedzwiecki D, Hollis D, et al. Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer; a randomized trial of efficacy, quality of life, and molecular markers. J Clin Oncol. 2006; 24: 1395–403.

    Article  PubMed  CAS  Google Scholar 

  34. Bilchik AJ, Wood TF, Allegra D, et al. Cryosurgery and radiofrequency ablation for unresectable hepatic malignancies: a proposed algorithm. Arch Surg. 2000; 135: 657–62.

    Article  PubMed  CAS  Google Scholar 

  35. Curley SA, Izzo F, Delrio P, et al. Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: results in 123 patients. Ann Surg. 2000; 230: 1–8.

    Article  Google Scholar 

  36. Scaife CL, Curley SA, Izzo F, et al. Feasibility of adjuvant hepatic arterial infusion of chemotherapy after radiofrequency ablation with or without resection in patients with hepatic metastases from colorectal cancer. Ann Surg Oncol. 2003; 10: 332–3.

    Article  Google Scholar 

  37. Wood TF, Rose DM, Chung M, et al. Radiofrequency ablation of 231 unresectable hepatic tumors: indications, limitations, and complications. Ann Surg Oncol. 2000; 7: 593–600.

    PubMed  CAS  Google Scholar 

  38. Weaver M, Ashton J, Zemel R. Treatment of colorectal liver metastases by cryotherapy. Semin Surg Oncol. 1998; 14: 163–70.

    Article  PubMed  CAS  Google Scholar 

  39. Yan TD, Padang R, Morris DL. Long term results and prognostic indicators after cryotherapy and hepatic arterial chemotherapy with or without resection for colorectal liver metastases in 224 patients: long term survival can be achieved in patients with multiple bilateral liver metastases. J Am Coll Surg. 2006; 202: 100–11.

    Article  PubMed  Google Scholar 

  40. Bilchik AJ, Wood TF, Chawla SP, et al. Systemic irinotecan or floxuridine chemotherapy prolongs survival after hepatic cryosurgery in patients with metastatic colon cancer refractory to 5-fluorouracil. Clin Colorectal Cancer. 2001; 1: 36–42.

    Article  PubMed  CAS  Google Scholar 

  41. Kemeny N, Jarnagin W, Gonen M, et al. Phase I/II study of hepatic arterial therapy with floxuridine and dexamethasone in combination with intravenous irinotecan as adjuvant treatment after resection of hepatic metastases from colorectal carcinoma. J Surg Oncol. 2005; 91: 97–101.

    Article  PubMed  CAS  Google Scholar 

  42. Litvak D, Wood T, Tsioulias G, Chung M, et al. Systemic irinotecan and regional floxuridine after hepatic cytoreduction in 185 patients with unresectable colorectal cancer metastases. Ann Surg Oncol. 2002; 9: 148–55.

    Article  PubMed  Google Scholar 

  43. Ducreux M, Ychou M, Laplanche A, et al. Hepatic arterial oxaliplatin infusion plus intravenous chemotherapy in colorectal cancer with inoperable hepatic metastases: a trial of the gastrointestinal group of the Federation Nationale des Centres de Lutte Contre le Cancer. J Clin Oncol. 2005; 23: 4881–7.

    Article  PubMed  CAS  Google Scholar 

  44. Lygidakis NJ, Bhagat AD, Vrachnos P, et al. Challenges in everyday surgical practice: synchronous bilobar hepatic colorectal metastases—newer multimodality approach. Hepatogastroenterology. 2007; 54: 1020–4.

    PubMed  CAS  Google Scholar 

  45. Bilchik AJ, Poston G, Curley SA, et al. Neoadjuvant chemotherapy for metastatic colon cancer: a cautionary note. J Clin Oncol. 2005; 23: 9073–8.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Surgical Oncology Fellow, John Wayne Cancer Institute at Saint John’s Health Center, Santa Monica, CA, USA

    Simon H. Telian

Authors
  1. Simon H. Telian
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Byron E. Wright
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Anton J. Bilchik
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. M.D. Anderson Cancer Center, Dept. Surgical Oncology, University of Texas, Holcombe Blvd. 1515, Houston, 77030, Texas, USA

    Jean-Nicolas Vauthey

  2. São Paulo, Faculdade de Medicina da, Universidade de São Paulo,, Instituto do Cancer do Estado de, Ave Dr Arnaldo 251, São Paulo, 01246-000, São Paulo, Brazil

    Paulo M. Hoff

  3. University of Liverpool, St Helens Teach, Marshalls Cross Road, St Helens, WA9 3DA, United Kingdom

    Riccardo A. Audisio

  4. Center for Digestive Diseases, University Hospital Aintree, Lower Lane, Liverpool, L9 7AL, United Kingdom

    Graeme J. Poston

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer-Verlag London

About this chapter

Cite this chapter

Telian, S.H., Wright, B.E., Bilchik, A.J. (2009). Locoregional Chemotherapy for Hepatic Metastasis of Colorectal Cancer. In: Vauthey, JN., Hoff, P., Audisio, R., Poston, G. (eds) Liver Metastases. Springer, London. https://doi.org/10.1007/978-1-84628-947-7_6

Download citation

  • DOI: https://doi.org/10.1007/978-1-84628-947-7_6

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-84628-946-0

  • Online ISBN: 978-1-84628-947-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation